CTX-M β-lactamase-producing Klebsiella pneumoniae in suburban New York, New York, USA

Emerging Infectious Diseases

Volumn 19, Issue 11, 2013, Pages 1803-1810

  Wang, Guiqing ^a   Huang, Tiangui ^a   Makam Surendraiah, Pavan Kumar ^a   Wang, Kemeng ^a   Komal, Rashida ^a   Zhuge, Jian ^a   Chern, Chian Ru ^a   Kryszuk, Alexander A ^a   King, Cassidy ^a   Wormser, Gary P ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BETA LACTAMASE; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; ERTAPENEM; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TETRACYCLINE; TIGECYCLINE;

ADULT; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIURIA; CLINICAL ARTICLE; DISK DIFFUSION; DNA SEQUENCE; ESCHERICHIA COLI; FEMALE; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; KLEBSIELLA PNEUMONIAE; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PULSED FIELD GEL ELECTROPHORESIS; RESPIRATORY TRACT INFECTION;

ANTIMICROBIAL RESISTANCE; BACTERIA; BETA-LACTAMASES CTX-M-15; ESCHERICHIA COLI; EXTENDED-SPECTRUM BETA-LACTAMASES; KLEBSIELLA PNEUMONIAE; MULTILOCUS SEQUENCE TYPING; PULSED-FIELD GEL ELECTROPHORESIS;

ADULT; AGED; BETA-LACTAMASES; ESCHERICHIA COLI; FEMALE; GENOTYPE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; NEW YORK CITY; PHYLOGENY; PREVALENCE; SUBURBAN POPULATION;

EID: 84887014590     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1911.121470     Document Type: Article

References (40)

1. Rossolini GM, D'Andrea MM, Mugnaioli C. The spread of CTXM-type extended-spectrum beta-lactamases. Clin Microbiol Infect. 2008; 14(Suppl 1): 33-41. http://dx. doi. org/10. 1111/j. 1469-0691. 2007. 01867. x.
2. Bonnet R. Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother. 2004; 48: 1-14. http://dx. doi. org/10. 1128/AAC. 48. 1. 1-14. 2004.
3. Paterson DL, Hujer KM, Hujer AM, Yeiser B, Bonomo MD, Rice LB, et al. Extended-spectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV-and CTX-M-type beta-lactamases. Antimicrob Agents Chemother. 2003; 47: 3554-60. http://dx. doi. org/10. 1128/AAC. 47. 11. 3554-3560. 2003.
4. Moland ES, Black JA, Hossain A, Hanson ND, Thomson KS, Pottumarthy S. Discovery of CTX-M-like extended-spectrum betalactamases in Escherichia coli isolates from five US States. Antimicrob Agents Chemother. 2003; 47: 2382-3. http://dx. doi. org/10. 1128/AAC. 47. 7. 2382-2383. 2003.
5. Lewis JS, Herrera M, Wickes B, Patterson JE, Jorgensen JH. First report of the emergence of CTX-M-type extended-spectrum betalactamases (ESBLs) as the predominant ESBL isolated in a U. S. health care system. Antimicrob Agents Chemother. 2007; 51: 4015-21. http://dx. doi. org/10. 1128/AAC. 00576-07.
6. Sidjabat HE, Paterson DL, Adams-Haduch JM, Ewan L, Pasculle AW, Muto CA, et al. Molecular epidemiology of CTX-M-producing Escherichia coli isolates at a tertiary medical center in western Pennsylvania. Antimicrob Agents Chemother. 2009; 53: 4733-9. http://dx. doi. org/10. 1128/AAC. 00533-09.
7. Johnson JR, Urban C, Weissman SJ, Jorgensen JH, Lewis JS II, Hansen G, et al. Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25: H4) and blaCTX-M-15 among extendedspectrum-beta-lactamase-producing E. coli from the United States, 2000 to 2009. Antimicrob Agents Chemother. 2012; 56: 2364-70. http://dx. doi. org/10. 1128/AAC. 05824-11.
8. Qi C, Pilla V, Yu JH, Reed K. Changing prevalence of Escherichia coli with CTX-M-type extended-spectrum beta-lactamases in outpatient urinary E. coli between 2003 and 2008. Diagn Microbiol Infect Dis. 2010; 67: 87-91. http://dx. doi. org/10. 1016/j. diagmicrobio. 2009. 12. 011.
9. Urban C, Mariano N, Bradford PA, Tuckman M, Segal-Maurer S, Wehbeh W, et al. Identification of CTX-M beta-lactamases in Escherichia coli from hospitalized patients and residents of longterm care facilities. Diagn Microbiol Infect Dis. 2010; 66: 402-6.
10. Tiruvury H, Johnson JR, Mariano N, Grenner L, Colon-Urban R, Erritouni M, et al. Identification of CTX-M beta-lactamases among Escherichia coli from the community in New York City. Diagn Microbiol Infect Dis. 2012; 72: 248-52. http://dx. doi. org/10. 1016/j. diagmicrobio. 2011. 11. 008.
11. McGettigan SE, Hu B, Andreacchio K, Nachamkin I, Edelstein PH. Prevalence of CTX-M beta-lactamases in Philadelphia, Pennsylvania. J Clin Microbiol. 2009; 47: 2970-4. http://dx. doi. org/10. 1128/JCM. 00319-09.
12. Castanheira M, Sader HS, Jones RN. Antimicrobial susceptibility patterns of KPC-producing or CTX-M-producing Enterobacteriaceae. Microb Drug Resist. 2010; 16: 61-5. http://dx. doi. org/10. 1089/mdr. 2009. 0031.
13. Sjölund M, Yam J, Schwenk J, Joyce K, Medalla F, Barzilay E, et al. Human Salmonella infection yielding CTX-M beta-lactamase, United States. Emerg Infect Dis. 2008; 14: 1957-9. http://dx. doi. org/10. 3201/eid1412. 080494.
14. Folster JP, Pecic G, Krueger A, Rickert R, Burger K, Carattoli A, et al. Identification and characterization of CTX-M-producing Shigella isolates in the United States. Antimicrob Agents Chemother. 2010; 54: 2269-70. http://dx. doi. org/10. 1128/AAC. 00039-10.
15. Hanson ND, Moland ES, Hong SG, Propst K, Novak DJ, Cavalieri SJ. Surveillance of community-based reservoirs reveals the presence of CTX-M, imported AmpC, and OXA-30 beta-lactamases in urine isolates of Klebsiella pneumoniae and Escherichia coli in a U. S. community. Antimicrob Agents Chemother. 2008; 52: 3814-6. http://dx. doi. org/10. 1128/AAC. 00877-08.
16. Lascols C, Hackel M, Hujer AM, Marshall SH, Bouchillon SK, Hoban DJ, et al. Using nucleic acid microarrays to perform molecular epidemiology and detect novel beta-lactamases: a snapshot of extended-spectrum beta-lactamases throughout the world. J Clin Microbiol. 2012; 50: 1632-9.
17. Castanheira M, Mendes RE, Rhomberg PR, Jones RN. Rapid emergence of blaCTX-M among Enterobacteriaceae in U. S. medical centers: molecular evaluation from the MYSTIC Program (2007). Microb Drug Resist. 2008; 14: 211-6. http://dx. doi. org/10. 1089/mdr. 2008. 0827.
18. Hoban DJ, Lascols C, Nicolle LE, Badal R, Bouchillon S, Hackel M, et al. Antimicrobial susceptibility of Enterobacteriaceae, including molecular characterization of extended-spectrum beta-lactamaseproducing species, in urinary tract isolates from hospitalized patients in North America and Europe: results from the SMART study 2009-2010. Diagn Microbiol Infect Dis. 2012; 74: 62-7. http://dx. doi. org/10. 1016/j. diagmicrobio. 2012. 05. 024.
19. Clinical Laboratory and Standards Institute. Performance standards for antimicrobial susceptibility testing: twentieth supplemental information. CLSI document M100-S20. Wayne (PA): The Institute; 2010.
20. Lomaestro BM, Tobin EH, Shang W, Gootz T. The spread of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae to upstate New York. Clin Infect Dis. 2006; 43: e26-8. http://dx. doi. org/10. 1086/505598.
21. Gröbner S, Linke D, Schutz W, Fladerer C, Madlung J, Autenrieth IB, et al. Emergence of carbapenem-non-susceptible extendedspectrum beta-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tubingen, Germany. J Med Microbiol. 2009; 58: 912-22. http://dx. doi. org/10. 1099/jmm. 0. 005850-0.
22. Moland ES, Hanson ND, Herrera VL, Black JA, Lockhart TJ, Hossain A, et al. Plasmid-mediated, carbapenem-hydrolysing betalactamase, KPC-2, in Klebsiella pneumoniae isolates. J Antimicrob Chemother. 2003; 51: 711-4. http://dx. doi. org/10. 1093/jac/dkg124.
23. Diancourt L, Passet V, Verhoef J, Grimont PA, Brisse S. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol. 2005; 43: 4178-82. http://dx. doi. org/10. 1128/JCM. 43. 8. 4178-4182. 2005.
24. Arlet G, Rouveau M, Casin I, Bouvet PJ, Lagrange PH, Philippon A. Molecular epidemiology of Klebsiella pneumoniae strains that produce SHV-4 beta-lactamase and which were isolated in 14 French hospitals. J Clin Microbiol. 1994; 32: 2553-8.
25. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis. 2010; 51: 286-94. http://dx. doi. org/10. 1086/653932.
26. Rogers BA, Sidjabat HE, Paterson DL. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother. 2011; 66: 1-14. http://dx. doi. org/10. 1093/jac/dkq415.
27. Titelman E, Iversen A, Kahlmeter G, Giske CG. Antimicrobial susceptibility to parenteral and oral agents in a largely polyclonal collection of CTX-M-14 and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae. APMIS. 2011; 119: 853-63. http://dx. doi. org/10. 1111/j. 1600-0463. 2011. 02766. x.
28. Shin J, Kim DH, Ko KS. Comparison of CTX-M-14-and CTXM-15-producing Escherichia coli and Klebsiella pneumoniae isolates from patients with bacteremia. J Infect. 2011; 63: 39-47. http://dx. doi. org/10. 1016/j. jinf. 2011. 05. 003.
29. Kuroda H, Yano H, Hirakata Y, Arai K, Endo S, Kanamori H, et al. Molecular characteristics of extended-spectrum beta-lactamaseproducing Escherichia coli in Japan: Emergence of CTX-M-15-producing E. coli ST131. Diagn Microbiol Infect Dis. 2012; 74: 201-3. http://dx. doi. org/10. 1016/j. diagmicrobio. 2012. 06. 011.
30. Ruiz de Alegría C, Rodriguez-Bano J, Cano ME, Hernandez-Bello JR, Calvo J, Roman E, et al. Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases in Spain: microbiological and clinical features. J Clin Microbiol. 2011; 49: 1134-6. http://dx. doi. org/10. 1128/JCM. 02514-10.
31. Clímaco EC, Minarini LA, da Costa Darini AL. CTX-M-producing Klebsiella spp. in a Brazilian hospital: what has changed in 6 years? Diagn Microbiol Infect Dis. 2010; 68: 186-9. http://dx. doi. org/10. 1016/j. diagmicrobio. 2010. 05. 013.
32. Pitout JD, Hossain A, Hanson ND. Phenotypic and molecular detection of CTX-M-beta-lactamases produced by Escherichia coli and Klebsiella spp. J Clin Microbiol. 2004; 42: 5715-21. http://dx. doi. org/10. 1128/JCM. 42. 12. 5715-5721. 2004.
33. Wang G, Kryszuk AA, Wang K, Granada M, Schwartz I, Wormser GP. Phenotypic and molecular characterization of carbapenem-resistant Klebsiella pneumoniae clinical isolates (2005-2010). Proceedings of the 111th American Society for Microbiology General Meeting, New Orleans, Louisiana, May 21-24, 2011. Washington: American Society for Microbiology. Abstract C-604.
34. Pournaras S, Protonotariou E, Voulgari E, Kristo I, Dimitroulia E, Vitti D, et al. Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece. J Antimicrob Chemother. 2009; 64: 348-52. http://dx. doi. org/10. 1093/jac/dkp207.
35. Sandegren L, Linkevicius M, Lytsy B, Melhus A, Andersson DI. Transfer of an Escherichia coli ST131 multiresistance cassette has created a Klebsiella pneumoniae-specific plasmid associated with a major nosocomial outbreak. J Antimicrob Chemother. 2012; 67: 74-83. http://dx. doi. org/10. 1093/jac/dkr405.
36. Karim A, Poirel L, Nagarajan S, Nordmann P. Plasmid-mediated extended-spectrum beta-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1. FEMS Microbiol Lett. 2001; 201: 237-41.
37. Oteo J, Cuevas O, Lopez-Rodriguez I, Banderas-Florido A, Vindel A, Perez-Vazquez M, et al. Emergence of CTX-M-15-producing Klebsiella pneumoniae of multilocus sequence types 1, 11, 14, 17, 20, 35 and 36 as pathogens and colonizers in newborns and adults. J Antimicrob Chemother. 2009; 64: 524-8. http://dx. doi. org/10. 1093/jac/dkp211.
38. Damjanova I, Toth A, Paszti J, Hajbel-Vekony G, Jakab M, Berta J, et al. Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamaseproducing Klebsiella pneumoniae epidemic clones in Hungary in 2005-the new 'MRSAs'? J Antimicrob Chemother. 2008; 62: 978-85. http://dx. doi. org/10. 1093/jac/dkn287.
39. Peirano G, Sang JH, Pitondo-Silva A, Laupland KB, Pitout JD. Molecular epidemiology of extended-spectrum-beta-lactamaseproducing Klebsiella pneumoniae over a 10 year period in Calgary, Canada. J Antimicrob Chemother. 2012; 67: 1114-20. http://dx. doi. org/10. 1093/jac/dks026.
40. Chen S, Hu F, Xu X, Liu Y, Wu W, Zhu D, et al. High prevalence of KPC-2-type carbapenemase coupled with CTX-M-type extended-spectrum beta-lactamases in carbapenem-resistant Klebsiella pneumoniae in a teaching hospital in China. Antimicrob Agents Chemother. 2011; 55: 2493-4. http://dx. doi. org/10. 1128/AAC. 00047-11.